NANOVIRICIDES, INC. Increase (Decrease) in Employee Related Liabilities
NANOVIRICIDES, INC. (NNVC) reported Increase (Decrease) in Employee Related Liabilities of $0 for the 12-month period ending 2014-06-30, per its 10-K filed 2014-09-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2014-11-14
- NANOVIRICIDES, INC. increase (decrease) in employee related liabilities for the quarter ending 2013-09-30 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in employee related liabilities for the quarter ending 2012-09-30 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in employee related liabilities for fiscal 2014 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in employee related liabilities for fiscal 2013 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in employee related liabilities for fiscal 2012 was $0.00.
- NANOVIRICIDES, INC. increase (decrease) in employee related liabilities for fiscal 2011 was -$22.92K.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 12 month | Increase (Decrease) in Employee Related Liabilities 99 month | Increase (Decrease) in Employee Related Liabilities 101 month |
|---|---|---|---|---|
| 2014-06-30 | $0.00 10-K · filed 2014-09-30 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-14 | $0.00 10-Q/A · filed 2013-11-18 | ||
| 2013-06-30 | $0.00 10-K · filed 2014-09-30 | $0.00 10-K/A · filed 2013-10-08 | ||
| 2012-09-30 | $0.00 10-Q/A · filed 2013-11-18 | |||
| 2012-06-30 | $0.00 10-K/A · filed 2013-10-08 | |||
| 2011-06-30 | -$22.92K 10-K/A · filed 2013-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |